Company news
Nutriband Inc. news in 2022
Nutriband Inc.'s news releases, calls and decks from 2022, newest first.
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023
December 28, 2022
Nutriband Approved for Dual Listing on Upstream
December 13, 2022
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3
December 4, 2022
Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent
November 30, 2022
Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines
November 7, 2022
Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement
October 26, 2022
Nutriband With Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics for AVERSA(TM) Fentanyl
October 3, 2022
Nutriband Inc. Announces Application for Dual Listing on Upstream
October 2, 2022
Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split
August 15, 2022
Nutriband Inc. Details of Seven-for-Six Forward Stock Split
August 9, 2022
Nutriband Receives Notice of Allowance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent
July 31, 2022
Nutriband Inc. Announces Seven-for-Six Forward Stock Split
July 26, 2022
Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market
July 21, 2022
Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares
July 14, 2022
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
May 19, 2022
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
May 16, 2022
Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
May 10, 2022
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
April 28, 2022
Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office
January 27, 2022
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology
January 17, 2022
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 9, 2022